[8] Photo-selective vaporisation of the prostate (PVP) with the 180-W GreenLight XPS laser, single-centre experience in high-risk patients

Objective: To evaluate the safety and efficacy of the 180-W GreenLight XPS laser for treating high-risk patients with benign prostatic hyperplasia (BPH) and to assess patient’s satisfaction with treatment. Methods: We retrospectively reviewed the charts of 44 high-risk patients who underwent PVP wit...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Riyad Al Mousa, Khadijah Eid, Ali Alabbad, Hend Alshamsi, Hamed Alali
Formato:	article
Lenguaje:	EN
Publicado:	Taylor & Francis Group 2018
Materias:	Diseases of the genitourinary system. Urology RC870-923
Acceso en línea:	https://doaj.org/article/b050f6e811e64b52b8d0687166d87ab6
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:b050f6e811e64b52b8d0687166d87ab6
record_format	dspace
spelling	oai:doaj.org-article:b050f6e811e64b52b8d0687166d87ab62021-12-02T12:24:08Z[8] Photo-selective vaporisation of the prostate (PVP) with the 180-W GreenLight XPS laser, single-centre experience in high-risk patients2090-598X10.1016/j.aju.2018.10.055https://doaj.org/article/b050f6e811e64b52b8d0687166d87ab62018-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2090598X18301499https://doaj.org/toc/2090-598XObjective: To evaluate the safety and efficacy of the 180-W GreenLight XPS laser for treating high-risk patients with benign prostatic hyperplasia (BPH) and to assess patient’s satisfaction with treatment. Methods: We retrospectively reviewed the charts of 44 high-risk patients who underwent PVP with the 180-W GreenLight XPS laser performed by a single surgeon between November 2013 and December 2016, with a follow-up of ⩾1 year. High-risk patients were classified as those who had at least one of the following: on anticoagulant therapy, urinary retention, or prostate size of >100 mL. Preoperative, intraoperative, postoperative, and long-term satisfaction were recorded. Results: In all, 44 patients were included in the study. The mean (range) age was 69.9 (55–88) years. All patients had at least one high-risk factor. In all, 30 patients had urinary retention, 12 had ischaemic heart disease on anticoagulant therapy, the mean (range) prostate size was 111.5 (40–250) mL, 20 patients had a prostate size of <100 mL, and the remaining 24 ⩾ 100 mL. There was renal impairment in six patients, bladder stones in two, previous transurethral resection of the prostate in four, haematuria in six, recurrent urinary tract infections (UTIs) in 11, urinary incontinence in six, and 29 patients had other lower urinary tract symptoms. The mean surgery time was 72.9 min, the mean energy used was 230705 W, the mean laser time was 32 min. One patient required postoperative intensive care unit admission due to a chest infection, one required blood transfusions, three developed UTIs, and one developed urethral stricture. The mean maximum urinary flow rate pre- and postoperatively was 9.7 mL/s and 13.1 mL/s, respectively (statistically significant by repeated measure ANOVA; P < 0.05). In patients with a prostate size of <100 mL, 90% were fully satisfied. All patients would recommend this procedure to others. In patients with a prostate size of ⩾100 mL, 19 were fully satisfied, two were not satisfied, and three did not complete the questionnaire. Conclusion: PVP with 180-W GreenLight XPS laser is an effective and safe modality of treatment in high-risk patients with BPH whatever the size of the prostate. Prospective randomised controlled studies with more patients are needed to further confirm these results.Riyad Al MousaKhadijah EidAli AlabbadHend AlshamsiHamed AlaliTaylor & Francis GrouparticleDiseases of the genitourinary system. UrologyRC870-923ENArab Journal of Urology, Vol 16, Iss , Pp S5-S6 (2018)
institution	DOAJ
collection	DOAJ
language	EN
topic	Diseases of the genitourinary system. Urology RC870-923
spellingShingle	Diseases of the genitourinary system. Urology RC870-923 Riyad Al Mousa Khadijah Eid Ali Alabbad Hend Alshamsi Hamed Alali [8] Photo-selective vaporisation of the prostate (PVP) with the 180-W GreenLight XPS laser, single-centre experience in high-risk patients
description	Objective: To evaluate the safety and efficacy of the 180-W GreenLight XPS laser for treating high-risk patients with benign prostatic hyperplasia (BPH) and to assess patient’s satisfaction with treatment. Methods: We retrospectively reviewed the charts of 44 high-risk patients who underwent PVP with the 180-W GreenLight XPS laser performed by a single surgeon between November 2013 and December 2016, with a follow-up of ⩾1 year. High-risk patients were classified as those who had at least one of the following: on anticoagulant therapy, urinary retention, or prostate size of >100 mL. Preoperative, intraoperative, postoperative, and long-term satisfaction were recorded. Results: In all, 44 patients were included in the study. The mean (range) age was 69.9 (55–88) years. All patients had at least one high-risk factor. In all, 30 patients had urinary retention, 12 had ischaemic heart disease on anticoagulant therapy, the mean (range) prostate size was 111.5 (40–250) mL, 20 patients had a prostate size of <100 mL, and the remaining 24 ⩾ 100 mL. There was renal impairment in six patients, bladder stones in two, previous transurethral resection of the prostate in four, haematuria in six, recurrent urinary tract infections (UTIs) in 11, urinary incontinence in six, and 29 patients had other lower urinary tract symptoms. The mean surgery time was 72.9 min, the mean energy used was 230705 W, the mean laser time was 32 min. One patient required postoperative intensive care unit admission due to a chest infection, one required blood transfusions, three developed UTIs, and one developed urethral stricture. The mean maximum urinary flow rate pre- and postoperatively was 9.7 mL/s and 13.1 mL/s, respectively (statistically significant by repeated measure ANOVA; P < 0.05). In patients with a prostate size of <100 mL, 90% were fully satisfied. All patients would recommend this procedure to others. In patients with a prostate size of ⩾100 mL, 19 were fully satisfied, two were not satisfied, and three did not complete the questionnaire. Conclusion: PVP with 180-W GreenLight XPS laser is an effective and safe modality of treatment in high-risk patients with BPH whatever the size of the prostate. Prospective randomised controlled studies with more patients are needed to further confirm these results.
format	article
author	Riyad Al Mousa Khadijah Eid Ali Alabbad Hend Alshamsi Hamed Alali
author_facet	Riyad Al Mousa Khadijah Eid Ali Alabbad Hend Alshamsi Hamed Alali
author_sort	Riyad Al Mousa
title	[8] Photo-selective vaporisation of the prostate (PVP) with the 180-W GreenLight XPS laser, single-centre experience in high-risk patients
title_short	[8] Photo-selective vaporisation of the prostate (PVP) with the 180-W GreenLight XPS laser, single-centre experience in high-risk patients
title_full	[8] Photo-selective vaporisation of the prostate (PVP) with the 180-W GreenLight XPS laser, single-centre experience in high-risk patients
title_fullStr	[8] Photo-selective vaporisation of the prostate (PVP) with the 180-W GreenLight XPS laser, single-centre experience in high-risk patients
title_full_unstemmed	[8] Photo-selective vaporisation of the prostate (PVP) with the 180-W GreenLight XPS laser, single-centre experience in high-risk patients
title_sort	[8] photo-selective vaporisation of the prostate (pvp) with the 180-w greenlight xps laser, single-centre experience in high-risk patients
publisher	Taylor & Francis Group
publishDate	2018
url	https://doaj.org/article/b050f6e811e64b52b8d0687166d87ab6
work_keys_str_mv	AT riyadalmousa 8photoselectivevaporisationoftheprostatepvpwiththe180wgreenlightxpslasersinglecentreexperienceinhighriskpatients AT khadijaheid 8photoselectivevaporisationoftheprostatepvpwiththe180wgreenlightxpslasersinglecentreexperienceinhighriskpatients AT alialabbad 8photoselectivevaporisationoftheprostatepvpwiththe180wgreenlightxpslasersinglecentreexperienceinhighriskpatients AT hendalshamsi 8photoselectivevaporisationoftheprostatepvpwiththe180wgreenlightxpslasersinglecentreexperienceinhighriskpatients AT hamedalali 8photoselectivevaporisationoftheprostatepvpwiththe180wgreenlightxpslasersinglecentreexperienceinhighriskpatients
_version_	1718394474034364416

[8] Photo-selective vaporisation of the prostate (PVP) with the 180-W GreenLight XPS laser, single-centre experience in high-risk patients

Ejemplares similares